Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value ($000): $1,293,496 (100.0% shares, 0.0% debt)

Holdings (35)

BMRN BIOMARIN PHARMACEUTICAL INC 12.8%
Value ($000) $164,964 Shares 2,139,614 Est. Cost $83.16 Unrealized +0.6%
ABIOMED INC 12.7%
Value ($000) $163,764 Shares 494,397 Est. Cost $81.43 Unrealized
INSM INSMED INC 10.7%
Value ($000) $138,211 Shares 5,881,299 Est. Cost $17.79 Unrealized +30.6%
UTHR UNITED THERAPEUTICS CORP 9.1%
Value ($000) $117,169 Shares 653,079 Est. Cost $89.23 Unrealized +113.5%
FOLD AMICUS THERAPEUTICS INC 7.3%
Value ($000) $93,789 Shares 9,903,761 Est. Cost $9.52 Unrealized -1.5%
STAA STAAR SURGICAL CO 7.0%
Value ($000) $90,855 Shares 1,136,968 Est. Cost $14.28 Unrealized +421.6%
REVANCE THERAPEUTICS INC 6.7%
Value ($000) $86,106 Shares 4,415,689 Est. Cost $21.99 Unrealized
BIIB BIOGEN INC 5.9%
Value ($000) $76,023 Shares 360,981 Est. Cost $264.06 Unrealized -17.6%
PRTA PROTHENA CORP PLC 4.8%
Value ($000) $61,492 Shares 1,681,477 Est. Cost $21.46 Unrealized +68.0%
ACAD ACADIA PHARMACEUTICALS INC 4.2%
Value ($000) $54,539 Shares 2,251,834 Est. Cost $33.89 Unrealized -28.6%
KARYOPHARM THERAPEUTICS INC 3.2%
Value ($000) $41,431 Shares 5,621,533 Est. Cost $16.36 Unrealized
SAGE THERAPEUTICS INC 2.2%
Value ($000) $28,192 Shares 851,719 Est. Cost $46.62 Unrealized
VNDA VANDA PHARMACEUTICALS INC 2.2%
Value ($000) $28,175 Shares 2,491,200 Est. Cost $11.21 Unrealized +17.2%
EHTH EHEALTH INC 1.6%
Value ($000) $20,505 Shares 1,652,260 Est. Cost $59.40 Unrealized -71.0%
ALGN ALIGN TECHNOLOGY INC 1.5%
Value ($000) $19,317 Shares 44,305 Est. Cost $114.31 Unrealized +325.8%
ALKS ALKERMES PLC 1.4%
Value ($000) $17,722 Shares 673,571 Est. Cost $22.36 Unrealized +10.8%
GOSS GOSSAMER BIO INC 1.2%
Value ($000) $15,249 Shares 1,756,757 Est. Cost $11.85 Unrealized -18.6%
KEZAR LIFE SCIENCES INC 0.8%
Value ($000) $10,906 Shares 656,200 Est. Cost $5.16 Unrealized
ANAB ANAPTYSBIO INC 0.8%
Value ($000) $10,664 Shares 431,024 Est. Cost $19.06 Unrealized +58.8%
SNDX SYNDAX PHARMACEUTICALS INC 0.8%
Value ($000) $10,647 Shares 612,600 Est. Cost $16.84 Unrealized +0.0%
GRITSTONE ONCOLOGY INC 0.7%
Value ($000) $9,602 Shares 2,330,504 Est. Cost $9.42 Unrealized
CLOVIS ONCOLOGY INC 0.7%
Value ($000) $9,037 Shares 4,473,967 Est. Cost $42.71 Unrealized
EPIZYME INC 0.6%
Value ($000) $7,791 Shares 6,774,541 Est. Cost $11.87 Unrealized
TVTX TRAVERE THERAPEUTICS INC 0.3%
Value ($000) $4,280 Shares 166,069 Est. Cost $23.56 Unrealized +12.7%
CYTK CYTOKINETICS INC 0.3%
Value ($000) $4,112 Shares 111,717 Est. Cost $6.71 Unrealized +429.3%
RIGEL PHARMACEUTICALS INC 0.2%
Value ($000) $1,951 Shares 652,395 Est. Cost $3.40 Unrealized
MIRM MIRUM PHARMACEUTICALS INC 0.1%
Value ($000) $1,425 Shares 64,700 Est. Cost $15.56 Unrealized +31.1%
MAGENTA THERAPEUTICS INC 0.1%
Value ($000) $1,254 Shares 432,300 Est. Cost $7.38 Unrealized
ALIMERA SCIENCES INC 0.1%
Value ($000) $1,125 Shares 200,919 Est. Cost $6.30 Unrealized
NVAX NOVAVAX INC 0.1%
Value ($000) $921 Shares 12,500 Est. Cost $171.82 Unrealized -48.1%
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value ($000) $715 Shares 160,800 Est. Cost $7.10 Unrealized -43.9%
TCMD TACTILE SYSTEMS TECHNOLOGY I 0.0%
Value ($000) $546 Shares 27,100 Est. Cost $39.74 Unrealized -56.0%
KLDO KALEIDO BIOSCIENCES INC 0.0%
Value ($000) $511 Shares 309,692 Est. Cost $13.76 Unrealized -87.0%
MARINUS PHARMACEUTICALS INC 0.0%
Value ($000) $293 Shares 31,330 Est. Cost $15.48 Unrealized
URGN UROGEN PHARMA LTD 0.0%
Value ($000) $213 Shares 24,500 Est. Cost $27.01 Unrealized -71.1%